< Back to previous page
Researcher
Koen Vermeulen
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Member
From22 Sep 2014 → 31 Dec 2020
Projects
1 - 1 of 1
- Development of trace substances for in vivo visualization of heat shock protein 90 using positron emission tomographyFrom23 Sep 2019 → 23 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 6 of 6
- Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells(2020)
Authors: Koen Vermeulen, Guy Bormans
- Design and Challenges of Radiopharmaceuticals(2019)
Authors: Koen Vermeulen, Mathilde Vandamme, Guy Bormans, Frederik Cleeren
Pages: 339 - 356 - Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma☆(2019)
Authors: Koen Vermeulen, Kaat Luyten, Guy Bormans
Pages: 1 - 11 - Development and evaluation of HDAC and Hsp90 PET ligands(2019)
Authors: Koen Vermeulen, Guy Bormans
- Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90(2019)
Authors: Koen Vermeulen, Evelyne Naus, Kaat Luyten, Sofie Celen, Joost Schymkowitz, Frederic Rousseau, Guy Bormans
Pages: 554 - 572 - Synthesis, Enzyme Assays and Molecular Docking Studies of Fluorinated Bioisosteres of Santacruzamate A as Potential HDAC Tracers(2017)
Authors: Koen Vermeulen, Mathy Froeyen, Guy Bormans
Pages: 787 - 797